Zhengye Biotechnology surges 13.99% on joint venture news

Zhengye Biotechnology Holding Ltd. (ZYBT) surged 13.99% in pre-market trading on April 4, 2025, marking a significant rise in its stock price.

Zhengye Biotechnology Holding Ltd. recently announced a strategic joint venture with Youjia Technology Consulting Service. The new company, Zhongnong Zhengye Biological Technology (Beijing) Co., Ltd., will focus on the sales of poultry vaccines manufactured by Jilin Zhengye. This move is expected to enhance Zhengye’s market presence in the biotechnology sector, particularly in the poultry vaccine market, and could potentially strengthen its operational capabilities and stakeholder value.

Zhengye Biotechnology Holding Ltd. operates in the biotechnology industry, focusing on the production and sale of biological products such as poultry vaccines. The company is based in Jilin Province, China, and aims to leverage its expertise in biotechnology to serve the agricultural sector. This joint venture is a significant step forward for Zhengye, as it seeks to expand its market reach and solidify its position in the biotechnology industry.